Clinical Data & Safety
REVIEW THE RESULTS
For questions call Anovo
Contact Recordati Rare Diseases Representative for additional information and ongoing support
CYSTADROPS (cysteamine ophthalmic solution) 0.37% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis.
INDICATIONS AND IMPORTANT SAFETY INFORMATION